A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. (Q54590599)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. |
scientific article |
Statements
A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. (English)
1 reference
Naokuni Uike
1 reference
Kosuke Tsuboi
1 reference
Toshiya Yokozawa
1 reference
Toru Sakura
1 reference
Takashi Watanabe
1 reference
Shin Fujisawa
1 reference
Takahiro Yamauchi
1 reference
Kiyoshi Ando
1 reference
Rika Kihara
1 reference
Kensei Tobinai
1 reference
Hiroya Asou
1 reference
Tomomitsu Hotta
1 reference
Shuichi Miyawaki
1 reference
11 May 2011
1 reference
35
1 reference
1384-1389
1 reference
10
1 reference
Identifiers
1 reference